AzTrials
AzTrials

Piriformis SyndromeNCT07769203

Effects of MET and MFR on Piriformis Syndrome

A study testing Muscle Energy Technique, Myofascial Release Technique and Conventional Physical Therapy in people with Piriformis Syndrome, run by Igdir University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this study is to comparatively evaluate the effects of two different manual therapy approaches, Muscle Energy Technique (MET) and Myofascial Release Technique (MFR), on pain threshold, muscle activation patterns, and muscle strength in individuals diagnosed with piriformis syndrome. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Piriformis Syndrome
What is being tested?
Muscle Energy Technique, Myofascial Release Technique and Conventional Physical Therapy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
1 siteTurkey (Türkiye)
Study dates
30 Aug 2026to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Individuals diagnosed with piriformis syndrome
  • Presence of piriformis tenderness and sciatic symptoms
  • Aged between 18 and 65 years
  • Voluntary agreement to participate in the study
  • No history of lumbar, hip, knee, or ankle surgery within the last year
  • Ability to cooperate with the assessment and treatment procedures

Who cannot join

  • Individuals younger than 18 years or older than 65 years
  • Presence of any musculoskeletal disorder affecting the lower extremity
  • Presence of neurological, cardiac, pulmonary, or orthopedic disorders preventing participation in exercise
  • Presence of neurological deficits (muscle strength loss)
  • History of radiotherapy to the lumbar or hip region
  • Absence from more than 20% of treatment sessions
Show all 11Show fewer
  • Inability to comply with the study procedures (e.g., cognitive impairment, communication problems, severe psychiatric disorders)
  • Corticosteroid or PRP injection within the last 3 months
  • Participation in another physical therapy program within the last 3 months
  • Use of analgesic, anti-inflammatory, or muscle relaxant medications within the last 48-72 hours
  • Use of psychotropic medications that may affect muscle activation or nervous system responses (e.g., antidepressants, antipsychotics, sedatives)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Nuran Akdağ Mirzaoğlu, Msc/PT/Lecture contact

+905058179557

ptnurank@gmail.com

Yavuz Yakut, Prof. Dr. contact

+905324181001

yavuz.yakut@hku.edu.tr

Turkey (Türkiye)1 site
  • Hasan Kalyoncu University Faculty of Health Sciences

    Gaziantep, Şehitkamil, 27000

    Nuran Akdağ Mirzaoğlu, Msc/PT/Lecture, +905058179557, ptnurank@gmail.com

    Yavuz Yakut, Prof. Dr., +905324181001, yavuz.yakut@hku.edu.tr

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Muscle Energy Technique and Myofascial Release Technique on Pain Threshold, Muscle Activation Pattern, and Muscle Strength in Piriformis Syndrome

The aim of this study is to comparatively evaluate the effects of two different manual therapy approaches, Muscle Energy Technique (MET) and Myofascial Release Technique (MFR), on pain threshold, muscle activation patterns, and muscle strength in individuals diagnosed with piriformis syndrome.

In this study, the physiological effects of both interventions on the musculoskeletal system will be assessed using objective measurement tools such as an algometer, digital dynamometer, and electromyography (EMG). The study aims to provide evidence-based data regarding the most effective and preferable manual therapy approach in the conservative treatment of piriformis syndrome.

Read the detailed description

Participants included in the study will complete the Sociodemographic Information Form, Oswestry Disability Index (ODI), Lower Extremity Functional Scale (LEFS), World Health Organization Quality of Life Scale Brief Form (WHOQOL-BREF), Pittsburgh Sleep Quality Index (PSQI), and the Short-Form McGill Pain Questionnaire (SF-MPQ).

Additionally, participants will undergo the 6-Minute Walk Test (6MWT). Lower extremity muscle strength will be evaluated using a digital dynamometer, pain threshold will be assessed with an algometer, and muscle activation patterns will be evaluated using surface electromyography (sEMG) in the FAIR position.

The entire assessment procedure will take approximately 30-40 minutes, and all measurements will be performed under standardized conditions by the same researcher.

This study is a randomized controlled experimental trial aiming to compare the effects of two different manual therapy approaches, Muscle Energy Technique (MET) and Myofascial Release Technique (MFR), on pain threshold, muscle activation patterns, and muscle strength in individuals diagnosed with piriformis syndrome.

The study is designed as a pretest-posttest trial. Participants will be randomly allocated into three groups: the MET group, the MFR group, and the control group. All groups will receive treatment for 8 weeks, with 2 sessions per week, totaling 16 treatment sessions.

Being tested
Muscle Energy Technique, Myofascial Release Technique, Conventional Physical Therapy
Keywords
Piriformis Syndrome, Muscle Energy Technique, Myofascial Release, Surface EMG, Pain Threshold, Muscle Strength, Rehabilitation
Medical subject headings
Piriformis Muscle Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Muscle Energy TechniqueProcedure or surgery

    Muscle Energy Technique (MET) will be applied to participants by a trained physiotherapist in addition to conventional physical therapy. The intervention will be performed for 8 weeks, 2 sessions per week, totaling 16 sessions. The technique will include voluntary muscle contractions followed by relaxation and stretching procedures targeting the piriformis muscle.

  • Myofascial Release TechniqueProcedure or surgery

    Myofascial Release Technique (MFR) will be applied to participants by a trained physiotherapist in addition to conventional physical therapy. The intervention will be performed for 8 weeks, 2 sessions per week, totaling 16 sessions. The technique will involve sustained manual pressure and soft tissue release techniques targeting the piriformis muscle and surrounding fascia.

  • Conventional Physical TherapyProcedure or surgery

    Participants in the control group will receive conventional physical therapy for 8 weeks, 2 sessions per week, totaling 16 sessions.

Study groups in NCT07769203
Study groupRoleWhat they receive
Muscle Energy Technique GroupExperimentalParticipants in this group will receive Muscle Energy Technique (MET) in addition to conventional physical therapy for 8 weeks, 2 sessions per week, totaling 16 sessions.
Receives: Procedure: Muscle Energy Technique
Myofascial Release Technique GroupExperimentalParticipants in this group will receive Myofascial Release Technique (MFR) in addition to conventional physical therapy for 8 weeks, 2 sessions per week, totaling 16 sessions.
Receives: Procedure: Myofascial Release Technique
Conventional Physical Therapy GroupActive comparatorParticipants in this group will receive conventional physical therapy for 8 weeks, 2 sessions per week, totaling 16 sessions.
Receives: Procedure: Conventional Physical Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pressure Pain Threshold

    Assessment of pressure pain threshold using an algometer.

    Measured: Baseline and after 8 weeks of treatment

Secondary outcomes (8)
  1. Pain Severity (SF-MPQ)

    Pain intensity and pain characteristics will be evaluated using the Short-Form McGill Pain Questionnaire (SF-MPQ). Higher scores indicate greater pain severity.

    Measured: Baseline and after 8 weeks of treatment

  2. Muscle Strength

    Assessment of lower extremity muscle strength using a digital dynamometer.

    Measured: Baseline and after 8 weeks of treatment

  3. Muscle Activation Pattern

    Assessment of muscle activation patterns using surface electromyography (sEMG) in the FAIR position.

    Measured: Baseline and after 8 weeks of treatment

  4. Lower Extremity Functional Scale (LEFS)

    Assessment of lower extremity functional status using the Lower Extremity Functional Scale (LEFS).

    Measured: Baseline and after 8 weeks of treatment

  5. Oswestry Disability Index (ODI)

    Assessment of disability level using the Oswestry Disability Index (ODI).

    Measured: Baseline and after 8 weeks of treatment

  6. World Health Organization Quality of Life Scale Brief Form (WHOQOL-BREF)

    Assessment of quality of life using the World Health Organization Quality of Life Scale Brief Form (WHOQOL-BREF).

    Measured: Baseline and after 8 weeks of treatment

  7. Sleep Quality (PSQI)

    Assessment of sleep quality using the Pittsburgh Sleep Quality Index (PSQI).

    Measured: Baseline and after 8 weeks of treatment

  8. 6-Minute Walk Test

    Assessment of functional exercise capacity using the 6-Minute Walk Test (6MWT).

    Measured: Baseline and after 8 weeks of treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Aug 2026
  2. Study start30 Aug 2026 (estimated)
  3. Primary completionNov 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned into three groups: the Muscle Energy Technique (MET) group, the Myofascial Release Technique (MFR) group, and the control group. All participants will receive treatment for 8 weeks, with 2 sessions per week, totaling 16 sessions. Outcome measures will be assessed before and after the intervention period.
Masking
Single blind
Who is masked
Participant
Enrolment
72 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07769203
Sponsor's protocol ID
HKU-PIR-MET-2026
Status last verified
Aug 2026
First submitted
12 Aug 2026
Last updated
17 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) sharing has not yet been determined. Data sharing plans may be evaluated after study completion in accordance with institutional policies and participant confidentiality.

Questions about this trial

What is this clinical trial studying?

A study testing Muscle Energy Technique, Myofascial Release Technique and Conventional Physical Therapy in people with Piriformis Syndrome, run by Igdir University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 17 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nuran Akdağ Mirzaoğlu, Msc/PT/Lecture (+905058179557, ptnurank@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pressure Pain Threshold (time frame: Baseline and after 8 weeks of treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in